Ryan Cassaday, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Amgen
    Topic: 
    B-cell ALL
    Date added: 
    05/30/2023
    Relationship end date: 
    08/01/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Kite
    Topic: 
    B-cell ALL
    Date added: 
    05/30/2023
    Relationship end date: 
    05/15/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Pfizer
    Topic: 
    B-cell ALL
    Date added: 
    05/30/2023
    Relationship end date: 
    05/31/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Servier
    Topic: 
    B-cell ALL
    Date added: 
    05/30/2023
    Relationship end date: 
    12/31/2025
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Incyte
    Topic: 
    B-cell ALL
    Date added: 
    05/30/2023
    Relationship end date: 
    01/30/2026
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Vanda
    Topic: 
    Hematologic Malignancy
    Date added: 
    05/30/2023
    Relationship end date: 
    04/30/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Amgen
    Topic: 
    Advisor: B-cell ALL
    Date added: 
    05/30/2023
    Relationship end date: 
    10/19/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Jazz
    Topic: 
    Advisor: B-cell ALL
    Date added: 
    05/30/2023
    Relationship end date: 
    11/21/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Kite
    Topic: 
    Advisor: B-cell ALL
    Date added: 
    05/30/2023
    Relationship end date: 
    01/13/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Pfizer
    Topic: 
    Advisor: B-cell ALL
    Date added: 
    05/30/2023
    Relationship end date: 
    04/14/2023

Pages

Return to Seattle Cellular Therapy Summit: Patient-Centered Approach to Improve Outcomes